1. United States Food and Drug Administration approved oral kinase inhibitors for the treatment of malignancies;Jeong;Curr Probl Cancer,2013
2. Ibrutinib (imbruvica): a novel targeted therapy for chronic lymphocytic leukemia;Parmar;P T,2014
3. Guideline for patients on antiplatelet agents undergoing elective, non-cardiac surgical intervention;Johnstone,2018
4. Oral anticoagulants (VKA and NOAC): guidelines for prescribing, monitoring and management;Foster,2015
5. Lancashire and South Cumbria Medicines Management Group. Low molecular weight heparins (LMWHs): summary prescribing guide. Available from URL: https://www.lancsmmg.nhs.uk/download/guidelines/Low-Molecular-Weigh-Heparins-Summary-Prescribing-guide-Version-1.4.pdf (last accessed 16 November 2019).